PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
Negative net income growth while LBL.AX stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.25%
Share change of 0.25% while LBL.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.00%
OCF growth of 0.00% while LBL.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
0.00%
FCF growth of 0.00% while LBL.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-29.23%
Negative 10Y revenue/share CAGR while LBL.AX stands at 236.77%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
220.47%
5Y revenue/share CAGR above 1.5x LBL.AX's 94.34%. David Dodd would look for consistent product or market expansions fueling outperformance.
106.00%
3Y revenue/share CAGR similar to LBL.AX's 108.21%. Walter Schloss would assume both companies experience comparable short-term cycles.
-243.98%
Negative 10Y OCF/share CAGR while LBL.AX stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-423.72%
Negative 5Y OCF/share CAGR while LBL.AX is at 2208.44%. Joel Greenblatt would question the firm’s operational model or cost structure.
-668.95%
Negative 3Y OCF/share CAGR while LBL.AX stands at 757.68%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
206.95%
Below 50% of LBL.AX's 1170.52%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
499.00%
5Y net income/share CAGR above 1.5x LBL.AX's 286.28%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
60.24%
Below 50% of LBL.AX's 835.29%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
1826.40%
5Y equity/share CAGR above 1.5x LBL.AX's 33.90%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
116.90%
3Y equity/share CAGR above 1.5x LBL.AX's 37.63%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.95%
AR growth of 7.95% while LBL.AX is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.25%
We have a declining book value while LBL.AX shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.